HIV Flashcards
Diagnosis of AIDS
1) CD4 < 200
2) AIDS-defining condition: opportunistic infections
Transmission of HIV
Blood, Semen, Vaginal, Rectal
BREASTMILK
Timing of Diagnosis Testing
1st) @ 2 weeks: HIV-1/HIV-2 Ag/Ab Immunoassay
2nd) @ 4-6 weeks: If (+), then Confirm with Antibody DIFFERENTIATION Immunoassay
- Determines if HIV-1 or HIV-2
3rd) @ 3 months: Ora-Quick Test
HIV Replication Steps & Rx Sites of Action: Step 1
Step 1) Binding /Attachment:
Maraviroc (Selzentry) = patient must have Trofile test for (+) CCR5 co-receptor to work
Ibalizumab-uiyk (Trogarzo)
HIV Replication Steps & Rx Sites of Action: Step 2
Step 2) Fusion
Enfuvirtide (Fuzeon)
HIV Replication Steps & Rx Sites of Action: Step 3
Step 3) Reverse Transcription
NRTI (Nucleoside Reverse Transcriptase Inhibitors)
NNRTI (Non-NRTI)
HIV Replication Steps & Rx Sites of Action: Step 4
Step 4) Integration
INSTI (Integrase Stand Transfer Inhibitors)
HIV Replication Steps & Rx Sites of Action: Step 5 / 6
Step 5) Transcription / Translation
Step 6) Assembly
NO DRUGS
HIV Replication Steps & Rx Sites of Action: Step 7
Step 7) Budding / Maturation
PI (Protease Inhibitors)
Initial Evalutation
1) CD4 count
2) HIV RNA Viral Load
3) Test HepB & Hep C
4) Pregnancy
Recommended Tx:
INSTI-based (1 INSTI + 1 or 2 NRTI)
One Pill, Once Daily
1) Biktarvy
2) Triumeq
3) Dovato
Biktarvy
Bictegravir (INSTI)
Emtricitiabine (NRTI)
TAF (NRTI)
Triumeq
Dolutegravir (INSTI)
Abacavir (NRTI)
Lamivudine (NRTI)
Dovato
Dolutegravir (INSTI)
Lamivudine (NRTI)
Two Pills
1) Tivicay + Truvada
2) Tivicay + Descovy
3) Isentress + Truvada
4) Isentress + Descovy
Tivicay
Dolutegravir
Preferred in Pregnancy
Isentress
Raltegravir
Myopathy / increase in CPK
Truvada
Emtricitabine + TDF
Descovy
Emtricitabine + TAF
Abacavir Brand / pharmacogenetic testing:
Ziagen
HLA-B*5701
Dovato Contraindications:
1) HIV RNA > 500k
2) Hep B co-infection
TAF vs TDF
TAF has less:
1) Renal toxicity
2) Bone loss
TDF by itself Brand Name
Viread
NRTI BBW/Warning
BBW: stavudine, zidovudine, didanosine 1) Lactic acidosis 2) Hepatomegaly with steatosis ADR = lipodystrophy stavudine / didanosine = pancreatitis zidovudine = anemia
Warning: TDF/TAF, abacavir, lamivudine
NRTI - HBV Treatments
Lamivudine (Epivir-HBV)
TDF (Vemlidy)
INSTI consideration:
Separate Al/Mg +2hr or -6hr
Raltegravir OK with Calcium Carbonate
Bictegravir OK with Ca or Fe if taken WITH FOOD
INSTI Side Effects
weight gain
insomnia
NNRTI (non-NRTIs) Brands
Atripla (EFAVIRENZ / emtricitabine / TDF)
Efavirenz ADR: psych issues, depression
Nevirapine
Rilpivirine
NNRTI - BBW
1) Hepatotoxicity
2) Severe Rash
*Worst with Nevirapine
Rilpivirine
1) WITH FOOD > 500 Cal
2) Requires ACIDIC pH (CI @ PPIs)
Protease Inhibitors - Side Effects
Metabolic ADRs:
1) Hyperglycemia
2) Hyperlipidemia
3) Lipodystrophy
- Least with:
1) atazanavir
2) darunavir
Protease Inhibitors - DDIs
CYP Inhibitors
Atazanvir Brand / consideration
Reyataz
1) Do NOT use with acid-lowering medications
2) Hyperbilirubinemia
Darunavir Brand
Prezista
Sulfa allergy Protease Inhibitors
Darunavir
Fosamprenavir
Tipranavir
Boosters
CYP3A4 Inhibitors:
1) Ritonavir
2) Cobicistat
CCR5 Antagonist / consideration
Miraviroc (Selzentry)
- requires CCR5-tropism assay
Fusion Inhibitor
Enfuvirtide (Fuzeon)
- SQ injection
Post-attachment Inhibitor
Ibalizumab-uiyk (Trogarzo)
- IV injection for MDR HIV only
Opportunistic Infections
OPPORTUNISTIC INFECTIONS: M. Avium Complex (MAC) Pneumocystis jiroveci pneumonia (PCP) Cryptococcus neoformans Histoplasmosis Severe Candida albicans Tuberculosis
Kaposi’s sarcoma (cancer)
HIV Wasting Syndrome (lipoatrophy, loss of muscle mass)
PrEP (Pre-Exposure Prophylaxis)
1) Truvada (TDF / emtricitabine)
2) Descovy (TAF / emtricitabine)
Baseline HIV test & HBV
Testing q 3 months
PEP (Post-Exposure Prophylaxis)
Truvada only (NOT Descovy) PLUS:
1) Dolutegravir (Tivicay)
2) Raltegravir (Isentress)
within 72 hrs for 28 days